Corvus Pharmaceuticals, Inc. short interest in 2026
In 2026, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 15.38% of shares outstanding on 15 Jan 2026 to 20.42% on 15 Sep 2026, a change of +5.04 percentage points. The year's high was 22.74% on 14 Aug 2026 and its low 15.38% on 15 Jan 2026, averaging 20.80% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.64 days on 31 Aug 2026. Full history: Corvus Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 15.38% (15 Jan 2026)
- End of year
- 20.42% (15 Sep 2026)
- Change
- +5.04 pp
- High
- 22.74% (14 Aug 2026)
- Low
- 15.38% (15 Jan 2026)
- Average
- 20.80%
- Highest days to cover
- 29.64 (31 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 15.38% | 7.54 | |
| 30 Jan 2026 | 19.65% | 1.09 | |
| 13 Feb 2026 | 19.93% | 9.81 | |
| 27 Feb 2026 | 21.44% | 13.29 | |
| 13 Mar 2026 | 19.11% | 14.71 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 20.18% | 11.09 | |
| 15 Apr 2026 | 20.15% | 21.77 | |
| 30 Apr 2026 | 21.89% | 11.54 | |
| 15 May 2026 | 22.51% | 11.98 | 10-Q filed, results (8-K) |
| 29 May 2026 | 20.63% | 8.45 | |
| 15 Jun 2026 | 21.29% | 14.37 | |
| 30 Jun 2026 | 22.41% | 12.38 | |
| 15 Jul 2026 | 21.50% | 12.59 | |
| 31 Jul 2026 | 21.80% | 22.50 | |
| 14 Aug 2026 | 22.74% | 22.53 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 22.61% | 29.64 | |
| 15 Sep 2026 | 20.42% | 18.16 |
See also: Corvus Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.